Fintel reports that on April 23, 2025, JMP Securities initiated coverage of Nuvation Bio (NYSE:NUVB) with a Market Outperform ...

On Monday, JMP Securities adjusted its price target on ... was further bolstered by DigitalOcean's announcement of upcoming product releases, including its GenAI Platform. This platform is ...

Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to ...

Monday, JMP Securities reiterated its Market Perform ... reflecting cautious optimism about its product development. Adicet Bio’s ongoing efforts in clinical trials and strategic initiatives ...

At this time, I would like to welcome everyone to the ServiceNow first-quarter 2025 earnings conference call. (Operator Instructions) Thank you. And I would now like to turn the conference over to ...

Monday, JMP Securities reiterated its Market Perform rating on Adicet Bio Inc ... H.C. Wainwright has maintained a Neutral rating on Adicet Bio, reflecting cautious optimism about its product ...

In a report released today, Nicholas Jones CFA from JMP Securities maintained a Buy rating on Amazon (AMZN – Research Report), with a price target of $285.00. The company’s shares closed ...

Q1 was another substantial acceleration for ServiceNow AI. The number of Pro Plus deals more than quadrupled year-over-year, including 39 deals with three or more Now Assist products. Average ACV deal ...